Novel lymphoma targets and agents
Andrew Zelenetz et al.
Evolving CLL treatments: creating choices and igniting discussions
Deborah Henderson et al.
Combination therapies and improving overall survival in AML
Myeloma XI trial: lenalidomide maintenance therapy for multiple myeloma
The potential of differentiation therapies for AML
Stéphane de Botton